Details
Stereochemistry | ACHIRAL |
Molecular Formula | C30H58O2 |
Molecular Weight | 450.7803 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCC
InChI
InChIKey=DYIOQMKBBPSAFY-BENRWUELSA-N
InChI=1S/C30H58O2/c1-3-5-7-9-11-13-15-16-17-19-21-23-25-27-29-32-30(31)28-26-24-22-20-18-14-12-10-8-6-4-2/h10,12H,3-9,11,13-29H2,1-2H3/b12-10-
Molecular Formula | C30H58O2 |
Molecular Weight | 450.7803 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Optical Activity | NONE |
Cetyl myristoleate (CMO) is the hexadecyl ester of myristoleic acid. Whereas myristoleic acid is commonly found in fish oils, whale oils, and dairy butter, CMO is known to exist only naturally in sperm whale oil and in a small gland in the male beaver. Cetyl myristoleate is effective in alleviating knee pain in persons with mild degree arthritis of the knee joint.
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Cetyl myristoleate isolated from Swiss albino mice: an apparent protective agent against adjuvant arthritis in rats. | 1994 Mar |
|
Osteoarthritis and nutrition. From nutraceuticals to functional foods: a systematic review of the scientific evidence. | 2006 |
|
The minimal effective dose of cis-9-cetylmyristoleate (CMO) in persons presenting with knee joint pain: A double-blind, randomized, placebo-controlled trial. | 2017 Mar |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:09:42 GMT 2023
by
admin
on
Fri Dec 15 17:09:42 GMT 2023
|
Record UNII |
87P8K33Q5X
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DSLD |
2997 (Number of products:36)
Created by
admin on Fri Dec 15 17:09:42 GMT 2023 , Edited by admin on Fri Dec 15 17:09:42 GMT 2023
|
||
|
FDA ORPHAN DRUG |
298309
Created by
admin on Fri Dec 15 17:09:42 GMT 2023 , Edited by admin on Fri Dec 15 17:09:42 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID001027162
Created by
admin on Fri Dec 15 17:09:42 GMT 2023 , Edited by admin on Fri Dec 15 17:09:42 GMT 2023
|
PRIMARY | |||
|
64660-84-0
Created by
admin on Fri Dec 15 17:09:42 GMT 2023 , Edited by admin on Fri Dec 15 17:09:42 GMT 2023
|
PRIMARY | |||
|
6443825
Created by
admin on Fri Dec 15 17:09:42 GMT 2023 , Edited by admin on Fri Dec 15 17:09:42 GMT 2023
|
PRIMARY | |||
|
C087638
Created by
admin on Fri Dec 15 17:09:42 GMT 2023 , Edited by admin on Fri Dec 15 17:09:42 GMT 2023
|
PRIMARY | |||
|
CETYL MYRISTOLEATE
Created by
admin on Fri Dec 15 17:09:42 GMT 2023 , Edited by admin on Fri Dec 15 17:09:42 GMT 2023
|
PRIMARY | |||
|
1314343
Created by
admin on Fri Dec 15 17:09:42 GMT 2023 , Edited by admin on Fri Dec 15 17:09:42 GMT 2023
|
PRIMARY | RxNorm | ||
|
275644
Created by
admin on Fri Dec 15 17:09:42 GMT 2023 , Edited by admin on Fri Dec 15 17:09:42 GMT 2023
|
PRIMARY | |||
|
100000086214
Created by
admin on Fri Dec 15 17:09:42 GMT 2023 , Edited by admin on Fri Dec 15 17:09:42 GMT 2023
|
PRIMARY | |||
|
87P8K33Q5X
Created by
admin on Fri Dec 15 17:09:42 GMT 2023 , Edited by admin on Fri Dec 15 17:09:42 GMT 2023
|
PRIMARY | |||
|
87P8K33Q5X
Created by
admin on Fri Dec 15 17:09:42 GMT 2023 , Edited by admin on Fri Dec 15 17:09:42 GMT 2023
|
PRIMARY | |||
|
SUB20626
Created by
admin on Fri Dec 15 17:09:42 GMT 2023 , Edited by admin on Fri Dec 15 17:09:42 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |